SCLX Q1 2021 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q1 2021 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$6M-6.3% YoY

Gross Profit

$5M84.6% margin

Operating Income

-$11M-205.4% margin

Net Income

-$19M-345.6% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

-6.3%

Cash Flow

Operating Cash Flow

-$494,332

Free Cash Flow

-$494,330

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$140M

Total Liabilities

$9M

Stockholders' Equity

$131M

Cash & Equivalents

$314,919

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	-6.3%
Gross Profit	$5M	$5M	-12.8%
Operating Income	-$11M	-$9M	-28.5%
Net Income	-$19M	-$12M	-60.5%